MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Accuray Incorporated EPS Ratio 2011-2026 | ARAY
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.02 | -0.16 | -0.1 | -0.06 | -0.07 | 0.04 | -0.19 | -0.28 | -0.36 | -0.32 | -0.51 | -0.47 | -1.41 | -1.02 | -0.44 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.04 | -1.41 | -0.358 |
Quarterly EPS Ratio Accuray Incorporated
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.11 | -0.18 | - | -0.01 | 0.03 | -0.04 | - | -0.06 | -0.1 | -0.03 | - | 0.01 | -0.02 | -0.06 | -0.08 | -0.01 | - | -0.01 | -0.01 | - | 0.05 | - | 0.05 | - | 0.12 | -0.11 | 0.12 | -0.01 | -0.05 | -0.11 | -0.05 | -0.11 | -0.06 | -0.11 | -0.06 | -0.06 | -0.11 | 0.01 | -0.09 | 0.01 | -0.08 | -0.16 | -0.08 | -0.04 | -0.13 | -0.28 | -0.13 | -0.28 | -0.07 | -0.21 | -0.07 | -0.21 | -0.4 | -0.34 | -0.28 | -0.21 | -0.15 | -0.38 | -0.15 | -0.02 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.12 | -0.4 | -0.0928 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K |  USA |
 |
AdaptHealth Corp.
AHCO
|
-0.52 | $ 13.19 | 0.81 % | $ 1.78 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
BioSig Technologies
BSGM
|
-9.65 | - | 37.08 % | $ 85.7 M | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | USA |
 |
Cardiovascular Systems
CSII
|
-0.94 | - | 0.15 % | $ 844 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-0.51 | $ 3.22 | -0.31 % | $ 121 M |  France |
 |
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Cytosorbents Corporation
CTSO
|
-0.13 | $ 0.61 | -0.33 % | $ 38 M | USA |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
Globus Medical
GMED
|
3.98 | $ 93.19 | -0.54 % | $ 12.6 B | USA |
 |
ClearPoint Neuro
CLPT
|
-0.9 | $ 11.33 | 1.07 % | $ 321 M | USA |
 |
Eargo
EAR
|
-39.7 | - | - | $ 10.2 M | USA |
 |
Electromed
ELMD
|
0.89 | $ 26.0 | - | $ 220 M | USA |
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | USA |
 |
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | USA |
 |
Helius Medical Technologies
HSDT
|
-14.6 | $ 2.09 | -1.42 % | $ 1.27 M | USA |
 |
LENSAR
LNSR
|
-2.87 | $ 5.28 | 1.34 % | $ 63.1 M | USA |
 |
Pulmonx Corporation
LUNG
|
-1.33 | $ 1.25 | -1.95 % | $ 50.9 M | USA |
 |
Butterfly Network
BFLY
|
-0.34 | $ 5.48 | - | $ 1.16 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-1.69 | $ 15.88 | 0.38 % | $ 373 M | USA |
 |
Delcath Systems
DCTH
|
0.08 | $ 10.8 | -0.37 % | $ 387 M | USA |
 |
Orthofix Medical
OFIX
|
-2.33 | $ 12.29 | -0.24 % | $ 487 M |  Curacao |
 |
LivaNova PLC
LIVN
|
-4.45 | $ 63.05 | -0.57 % | $ 3.44 B |  Britain |
 |
IRIDEX Corporation
IRIX
|
-0.26 | $ 1.07 | -1.37 % | $ 18.1 M | USA |
 |
CONMED Corporation
CNMD
|
1.52 | $ 37.58 | -0.77 % | $ 1.17 B | USA |
 |
Inspire Medical Systems
INSP
|
4.95 | $ 55.14 | 0.13 % | $ 1.62 B | USA |
 |
Integer Holdings Corporation
ITGR
|
2.96 | $ 85.43 | 0.09 % | $ 2.97 B | USA |
 |
Invacare Corporation
IVC
|
-0.54 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.84 | $ 83.85 | 0.47 % | $ 49 B | USA |
 |
Sintx Technologies
SINT
|
-6.16 | $ 2.42 | 3.03 % | $ 6.71 M | USA |
 |
MiMedx Group
MDXG
|
0.33 | $ 3.35 | 0.3 % | $ 495 M | USA |
 |
Stryker Corporation
SYK
|
2.21 | $ 328.23 | -0.24 % | $ 125 B | USA |
 |
NanoVibronix
NAOV
|
-26.7 | - | - | $ 1.08 M | USA |
 |
Tactile Systems Technology
TCMD
|
0.83 | $ 23.83 | -1.69 % | $ 545 M | USA |
 |
TELA Bio
TELA
|
-0.83 | $ 0.82 | 2.51 % | $ 38.5 M | USA |